|
1
|
Tarugi P, Averna M, Di Leo E, Cefalù AB,
Noto D, Magnolo L, Cattin L, Bertolini S and Calandra S:
Corrigendum to ‘Molecular diagnosis of hypobetalipoproteinemia: An
ENID review’ [Atherosclerosis 195 (2) (2007) 19–27].
Atherosclerosis. 253:e12016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Shah P, Bajaj S, Virk H, Bikkina M and
Shamoon F: Rapid progression of coronary atherosclerosis: A review.
Thrombosis. 2015:6349832015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Boesen ME, Singh D, Menon BK and Frayne R:
A systematic literature review of the effect of carotid
atherosclerosis on local vessel stiffness and elasticity.
Atherosclerosis. 243:211–222. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kousios A, Kouis P and Panayiotou AG:
Matrix metalloproteinases and subclinical atherosclerosis in
chronic kidney disease: A systematic review. Int J Nephrol.
2016:94980132016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ayyappan Plakkal J, Paul A and Goo YH:
Lipid droplet-associated proteins in atherosclerosis (Review). Mol
Med Rep. 13:4527–4534. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Gholami S, Salavati A, Houshmand S, Werner
TJ and Alavi A: Assessment of atherosclerosis in large vessel
walls: A comprehensive review of FDG-PET/CT image acquisition
protocols and methods for uptake quantification. J Nucl Cardiol.
22:468–479. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Crickx E, Saussine A, Vignon-Pennamen MD,
Cordoliani F, Mouly F, Bagot M and Rybojad M: Diffuse dermal
angiomatosis associated with severe atherosclerosis: Two cases and
review of the literature. Clin Exp Dermatol. 40:521–524. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Merashli M, Ster IC and Ames PR:
Subclinical atherosclerosis in Behcet's disease: A systematic
review and meta-analysis. Semin Arthritis Rheum. 45:502–510. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Shah NR and Mahmoudi M: The role of DNA
damage and repair in atherosclerosis: A review. J Mol Cell Cardiol.
86:147–157. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Olubamwo OO, Onyeka IN, Miettola J,
Kauhanen J and Tuomainen TP: Hepatitis C as a risk factor for
carotid atherosclerosis-a systematic review. Clin Physiol Funct
Imaging. 36:249–260. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Eto K: FGF-21, a newcomer in the field of
hypertension research. J Hum Hypertens. 27:343–344. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Reinehr T, Woelfle J, Wunsch R and Roth
CL: Fibroblast growth factor 21 (FGF-21) and its relation to
obesity, metabolic syndrome, and nonalcoholic fatty liver in
children: A longitudinal analysis. J Clin Endocrinol Metab.
97:2143–2150. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Suomalainen A, Elo JM, Pietiläinen KH,
Hakonen AH, Sevastianova K, Korpela M, Isohanni P, Marjavaara SK,
Tyni T, Kiuru-Enari S, et al: FGF-21 as a biomarker for
muscle-manifesting mitochondrial respiratory chain deficiencies: A
diagnostic study. Lancet Neurol. 10:806–818. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lin Z, Wu Z, Yin X, Liu Y, Yan X, Lin S,
Xiao J, Wang X, Feng W and Li X: Serum levels of FGF-21 are
increased in coronary heart disease patients and are independently
associated with adverse lipid profile. PLoS One. 5:e155342010.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ren G, Yin J, Wang W, Li L and Li D:
Fibroblast growth factor (FGF)-21 signals through both FGF
receptor-1 and 2. Sci China Life Sci. 53:1000–1008. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kharitonenkov A, Dunbar JD, Bina HA,
Bright S, Moyers JS, Zhang C, Ding L, Micanovic R, Mehrbod SF,
Knierman MD, et al: FGF-21/FGF-21 receptor interaction and
activation is determined by betaKlotho. J Cell Physiol. 215:1–7.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kharitonenkov A, Shiyanova TL, Koester A,
Ford AM, Micanovic R, Galbreath EJ, Sandusky GE, Hammond LJ, Moyers
JS, Owens RA, et al: FGF-21 as a novel metabolic regulator. J Clin
Invest. 115:1627–1635. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
18
|
Salehi MH, Kamalidehghan B, Houshmand M,
Aryani O, Sadeghizadeh M and Mossalaeie MM: Association of
fibroblast growth factor (FGF-21) as a biomarker with primary
mitochondrial disorders, but not with secondary mitochondrial
disorders (Friedreich Ataxia). Mol Biol Rep. 40:6495–6499. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Gahete MD, Córdoba-Chacón J, Luque RM and
Kineman RD: The rise in growth hormone during starvation does not
serve to maintain glucose levels or lean mass but is required for
appropriate adipose tissue response in female mice. Endocrinology.
154:263–269. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yu D, Sun CY, Sun GP, Ren GP, Ye XL, Zhu
SL, Wang WF, Xu PF, Li SJ, Wu Q, et al: The synergistic effect of
FGF-21 and insulin on regulating glucose metabolism and its
mechanism. Yao Xue Xue Bao. 49:977–984. 2014.(In Chinese).
PubMed/NCBI
|
|
21
|
Matuszek B, Lenart-Lipińska M, Duma D,
Solski J and Nowakowski A: Evaluation of concentrations of FGF-21-a
new adipocytokine in type 2 diabetes. Endokrynol Pol. 61:50–54.
2010.PubMed/NCBI
|
|
22
|
Yu Y, Bai F, Wang W, Liu Y, Yuan Q, Qu S,
Zhang T, Tian G, Li S, Li D and Ren G: Fibroblast growth factor 21
protects mouse brain against D-galactose induced aging via
suppression of oxidative stress response and advanced glycation end
products formation. Pharmacol Biochem Behav. 133:122–131. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
In: Guidance for the Description of Animal
Research in Scientific Publications. Washington, DC: 2011
|
|
24
|
Sartang Mohammadi M, Mazloomi SM, Tanideh
N and Zadeh Rezaian A: The effects of probiotic soymilk fortified
with omega-3 on blood glucose, lipid profile, haematological and
oxidative stress and inflammatory parameters in streptozotocin
nicotinamide-induced diabetic rats. J Diabetes Res.
2015:6963722015.PubMed/NCBI
|
|
25
|
Xiao S, Wang J and Xiao N: MicroRNAs as
noninvasive biomarkers in bladder cancer detection: A diagnostic
meta-analysis based on qRT-PCR data. Int J Biol Markers.
31:e276–e285. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wai-Hoe L, Wing-Seng L, Ismail Z and
Lay-Harn G: SDS-PAGE-based quantitative assay for screening of
kidney stone disease. Biol Proced Online. 11:145–160. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yahav G, Hirshberg A, Salomon O, Amariglio
N, Trakhtenbrot L and Fixler D: Fluorescence lifetime imaging of
DAPI-stained nuclei as a novel diagnostic tool for the detection
and classification of B-cell chronic lymphocytic leukemia.
Cytometry A. 89:644–652. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Mallavia B, Recio C, Oguiza A, Ortiz-Muñoz
G, Lazaro I, Lopez-Parra V, Lopez-Franco O, Schindler S, Depping R,
Egido J and Gomez-Guerrero C: Peptide inhibitor of NF-κB
translocation ameliorates experimental atherosclerosis. Am J
Pathol. 182:1910–1921. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wong MC, Zhang DX and Wang HH: Rapid
emergence of atherosclerosis in Asia: A systematic review of
coronary atherosclerotic heart disease epidemiology and
implications for prevention and control strategies. Curr Opin
Lipidol. 26:257–269. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Singh TP, Vangaveti VN and Malabu UH:
Dipeptidyl peptidase-4 inhibitors and their potential role in the
management of atherosclerosis-A review. Diabetes Metab Syndr.
9:223–229. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Wu GC, Leng RX, Lu Q, Fan YG, Wang DG and
Ye DQ: Subclinical atherosclerosis in patients with inflammatory
bowel diseases: A systematic review and meta-analysis. Angiology.
68:447–461. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Cuspidi C, Sala C, Tadic M, Gherbesi E,
Grassi G and Mancia G: Nondipping pattern and carotid
atherosclerosis: A systematic review and meta-analysis. J
Hypertens. 34:385–392. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Chartoumpekis DV, Habeos IG, Ziros PG,
Psyrogiannis AI, Kyriazopoulou VE and Papavassiliou AG: Brown
adipose tissue responds to cold and adrenergic stimulation by
induction of FGF21. Mol Med. 17:736–740. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Charoenphandhu N, Suntornsaratoon P,
Krishnamra N, Sa-Nguanmoo P, Tanajak P, Wang X, Liang G, Li X,
Jiang C, Chattipakorn N and Chattipakorn S: Fibroblast growth
factor-21 restores insulin sensitivity but induces aberrant bone
microstructure in obese insulin-resistant rats. J Bone Miner Metab.
35:142–149. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Fan H, Sun X, Zhang H, Liu J, Zhang P, Xu
Y, Pan Q and Wang G: Effect of metformin on fibroblast growth
factor-21 levels in patients with newly diagnosed type 2 diabetes.
Diabetes Technol Ther. 18:120–126. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Wang G, Liu J, Yang N, Hu Y, Zhang H, Miao
L, Yao Z and Xu Y: Levothyroxine treatment restored the decreased
circulating fibroblast growth factor 21 levels in patients with
hypothyroidism. Eur J Intern Med. 31:94–98. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Chen Y, Zhao H and Ren X: Estrogen and
progestogen inhibit NF-κB in atherosclerotic tissues of
ovariectomized ApoE (−/-) mice. Climacteric. 19:357–363. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Hsueh TP, Sheen JM, Pang JH, Bi KW, Huang
CC, Wu HT and Huang ST: The anti-atherosclerotic effect of naringin
is associated with reduced expressions of cell adhesion molecules
and chemokines through NF-κB Pathway. Molecules. 21:pii: E195.
2016. View Article : Google Scholar
|
|
39
|
Qiu L, Xu R, Wang S, Li S, Sheng H, Wu J
and Qu Y: Honokiol ameliorates endothelial dysfunction through
suppression of PTX3 expression, a key mediator of
IKK/IkappaB/NF-κB, in atherosclerotic cell model. Exp Mol Med.
47:e1712015. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Kim KM, Choi JY, Yoo SE, Park MY, Lee BS,
Ko YH, Sung SH, Shin HM and Park JE: HMCO5, herbal extract,
inhibits NF-kappaB expression in lipopolysaccharide treated
macrophages and reduces atherosclerotic lesions in cholesterol fed
mice. J Ethnopharmacol. 114:316–324. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Asare Y, Shagdarsuren E, Schmid JA,
Tilstam PV, Grommes J, El Bounkari O, Schütz AK, Weber C, de
Winther MP, Noels H and Bernhagen J: Endothelial CSN5 impairs NF-κB
activation and monocyte adhesion to endothelial cells and is highly
expressed in human atherosclerotic lesions. Thromb Haemost.
110:141–152. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Sun R, Xiao L and Duan S: High expression
of ubiquitin conjugates and NF-κB in unstable human intracranial
atherosclerotic plaques. J Cell Physiol. 227:784–788. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Sigala F, Savvari P, Liontos M, Sigalas P,
Pateras IS, Papalampros A, Basdra EK, Kolettas E, Papavassiliou AG
and Gorgoulis VG: Increased expression of bFGF is associated with
carotid atherosclerotic plaques instability engaging the NF-κB
pathway. J Cell Mol Med. 14:2273–2280. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Pan S, Lei L, Chen S, Li H and Yan F:
Rosiglitazone impedes Porphyromonas gingivalis-accelerated
atherosclerosis by downregulating the TLR/NF-κB signaling pathway
in atherosclerotic mice. Int Immunopharmacol. 23:701–708. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Ye X, Jiang X, Guo W, Clark K and Gao Z:
Overexpression of NF-κB p65 in macrophages ameliorates
atherosclerosis in apoE-knockout mice. Am J Physiol Endocrinol
Metab. 305:E1375–E1383. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Lazaro I, Oguiza A, Recio C, Mallavia B,
Madrigal-Matute J, Blanco J, Egido J, Martin-Ventura JL and
Gomez-Guerrero C: Targeting HSP90 ameliorates nephropathy and
atherosclerosis through suppression of NF-κB and STAT signaling
pathways in diabetic mice. Diabetes. 64:3600–3613. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Bhat OM, Kumar PU, Giridharan NV, Kaul D,
Kumar MJ and Dhawan V: Interleukin-18-induced atherosclerosis
involves CD36 and NF-κB crosstalk in Apo E−/− mice. J Cardiol.
66:28–35. 2015. View Article : Google Scholar : PubMed/NCBI
|
